Amyl Therapeutics has raised €8.25m to generate preclinical data for [...]

A $3m research programme will fund four projects investigating the [...]

Researchers at Dongguk University in South Korea have developed an [...]

Alamar Biosciences is expanding a partnership with the Alzheimer’s Disease [...]

AC Immune has outlined a series of clinical milestones expected [...]

ProMIS Neurosciences has reported six-month interim safety and biomarker data [...]

A two-minute digital cognitive assessment developed by Cumulus Neuroscience performed [...]

ProMIS Neurosciences has reported the first human evidence that its [...]

New Phase 1 data show Vandria’s VNA-318 reaches the human [...]

Alamar Biosciences has launched what it describes as the first [...]